<p>信诺保险集团（NYSE:CI - 获取免费报告）在周三发布的一份报告中，Wolfe Research 的股票分析师将其目标价从 345.00 美元下调至 325.00 美元，MarketScreener 报道。该公司目前对这家健康服务提供商的股票给予 “跑赢大盘” 的评级。Wolfe Research 的目标价意味着该股票当前价格有 9.85% 的潜在上涨空间。</p>
<ul>
<li>联合健康集团：从被排斥到买入的最佳时机</li>
</ul>
<p>其他股票分析师最近也对该股票发布了报告。Cantor Fitzgerald 在 8 月 26 日的研究报告中重申了 “增持” 评级，并对信诺保险集团的股票设定了 365.00 美元的目标价。高盛集团在周二的研究报告中开始覆盖信诺保险集团的股票，给予 “买入” 评级，并设定 370.00 美元的目标价。Guggenheim 在 8 月 4 日的研究报告中重申了 “买入” 评级，并将信诺保险集团的目标价从 388.00 美元下调至 350.00 美元。富国银行在 10 月 7 日的研究报告中将信诺保险集团的目标价从 340.00 美元上调至 354.00 美元，并给予该股票 “持平” 的评级。最后，Truist Financial 在 9 月 2 日的研究报告中设定了 375.00 美元的目标价。两位股票研究分析师给予该股票 “强烈买入” 评级，十六位分析师给予 “买入” 评级，三位分析师给予 “持有” 评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “适度买入”，共识目标价为 369.89 美元。</p>
<p><strong>阅读我们对信诺保险集团的最新分析</strong></p>
<h2>信诺保险集团价格表现</h2>
<ul>
<li>尽管医疗保险优势损失，Humana 仍然获利——其中有什么猫腻？</li>
</ul>
<p>信诺保险集团的 CI 股票在周三开盘价为 295.86 美元。该公司的 50 日移动平均线为 295.86 美元，200 日移动平均线为 308.87 美元。信诺保险集团的 12 个月低点为 256.89 美元，12 个月高点为 358.88 美元。该公司的流动比率为 0.71，速动比率为 0.71，债务与股本比率为 0.65。该公司的市值为 789.7 亿美元，市盈率为 16.14，PEG 比率为 0.87，贝塔值为 0.45。</p>
<p>信诺保险集团（NYSE:CI - 获取免费报告）最后一次发布季度收益数据是在 7 月 31 日，健康服务提供商报告每股收益（EPS）为 7.20 美元，超出市场共识预期的 7.15 美元，超出 0.05 美元。信诺保险集团的股本回报率为 18.80%，净利润率为 1.92%。该公司在本季度的收入为 671.3 亿美元，而市场共识预期为 626.1 亿美元。在去年同期，该公司每股收益为 6.72 美元。与去年同期相比，该公司的季度收入增长了 11.0%。信诺保险集团已将其 2025 财年的指导目标设定为 29.600-每股收益。整体来看，股票分析师预计信诺保险集团在当前财年将发布 29.77 美元的每股收益。</p>
<h2>内部买卖情况</h2>
<ul>
<li>MarketBeat 周回顾 – 01/06 - 01/10</li>
</ul>
<p>在信诺保险集团的其他新闻中，内部人士 Nicole S. Jones 在 8 月 15 日的交易中出售了 28,526 股信诺保险集团的股票。该股票以 300.00 美元的平均价格出售，总交易额为 8,557,800.00 美元。交易完成后，该内部人士持有该公司 25,648 股股票，价值 7,694,400 美元。这笔交易代表其持股比例减少了 52.66%。该出售在向 SEC 的备案中披露，相关信息可在此链接中找到。此外，内部人士 Brian C. Evanko 在 10 月 3 日的交易中出售了 5,368 股信诺保险集团的股票。该股票以 300.00 美元的平均价格出售，总交易额为 1,610,400.00 美元。交易完成后，该内部人士直接持有该公司 51,182 股股票，价值约 15,354,600 美元。这笔交易代表其持股比例减少了 9.49%。该出售的披露信息可以在这里找到。公司内部人士持有该公司 0.70% 的股票。</p>
<h2>机构资金流入和流出</h2>
<p>大型投资者最近对该股票的持仓进行了调整。Price T Rowe Associates Inc. MD 在第一季度将其在信诺保险集团的持股增加了 10.0%。Price T Rowe Associates Inc. MD 目前持有信诺保险集团的 12,056,806 股股票，价值为 39,666,900,000 美元，在此期间又增持了 1,094,327 股。马萨诸塞金融服务公司在第二季度将其在信诺保险集团的持股增加了 1.1%。马萨诸塞金融服务公司目前持有信诺保险集团的 11,778,472 股股票，价值为 38,937,270,000 美元，在上个季度又增持了 123,479 股。Dodge &amp; Cox 在第二季度将其在信诺保险集团的持股增加了 0.7%。Dodge &amp; Cox 目前持有信诺保险集团的 8,950,610 股股票，价值为 29,588,930,000 美元，在上个季度又增持了 60,877 股。GQG Partners LLC 在第一季度将其在信诺保险集团的持股增加了 21.5%。GQG Partners LLC 目前持有信诺保险集团的 4,886,674 股股票，价值为 16,077,160,000 美元，在上个季度又增持了 865,092 股。最后，Valeo Financial Advisors LLC 在第二季度将其在信诺保险集团的持股增加了 86,071.1%。Valeo Financial Advisors LLC 目前持有信诺保险集团的 3,475,282 股股票，价值为 1,148,859,000 美元，在上个季度又增持了 3,471,249 股。机构投资者和对冲基金持有该公司 86.99% 的股票。</p>
<h2>关于信诺保险集团</h2>
<p>（获取免费报告）</p>
<p>信诺集团及其子公司在美国提供保险及相关产品和服务。其 Evernorth 健康服务部门提供一系列协调和定点解决方案的健康服务，包括药房福利、家庭送药、专科药房、分销以及向健康计划、雇主、政府组织和医疗服务提供者提供的护理交付和管理解决方案。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票：信诺集团</li>
<li>异常交易量的股票：如何实时找到异常交易量股票</li>
<li>达美乐披露第三季度业绩超预期——并提供反弹的食谱</li>
<li>成长投资：你应该在 2022 年采用这种投资策略吗？</li>
<li>3 只小盘股创 52 周新高：获利了结还是继续持有？</li>
<li>什么是微型股？你需要知道的一切</li>
<li>Fluence Energy 可能是能源技术领域的多倍收益投资</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNJ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNJ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 $1,000 在信诺集团吗？</h2>
<p>在你考虑信诺集团之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而信诺集团并不在名单上。</p>
<p>虽然信诺集团目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

信诺保险

<p>Wolfe Research 将信诺保险（NYSE:CI）的目标股价从 345.00 美元下调至 325.00 美元，同时维持 “跑赢大盘” 的评级。这个新目标暗示从当前股价来看，潜在上涨幅度为 9.85%。其他分析师的评级和目标股价各不相同，平均共识目标价为 369.89 美元。信诺保险报告了强劲的季度收益，超出预期，市值为 789.7 亿美元。近期的内部交易显示公司内部人士进行了大量股票出售</p>

<p>Cigna Group (NYSE:CI - Get Free Report) had its price objective lowered by stock analysts at Wolfe Research from $345.00 to $325.00 in a report issued on Wednesday,MarketScreener reports. The firm presently has an &#34;outperform&#34; rating on the health services provider's stock. Wolfe Research's target price would indicate a potential upside of 9.85% from the stock's current price.</p>
<div class="lb-trans"><p>信诺保险集团（NYSE:CI - 获取免费报告）在周三发布的一份报告中，Wolfe Research 的股票分析师将其目标价从 345.00 美元下调至 325.00 美元，MarketScreener 报道。该公司目前对这家健康服务提供商的股票给予 “跑赢大盘” 的评级。Wolfe Research 的目标价意味着该股票当前价格有 9.85% 的潜在上涨空间。</p>
</div><ul>
<li>UnitedHealth Group: Pariah to Pole Position to Buy the Dip Levels</li>
</ul>
<div class="lb-trans"><ul>
<li>联合健康集团：从被排斥到买入的最佳时机</li>
</ul>
</div><p>Other equities analysts have also recently issued reports about the stock. Cantor Fitzgerald reissued an &#34;overweight&#34; rating and issued a $365.00 price objective on shares of Cigna Group in a research report on Tuesday, August 26th. The Goldman Sachs Group assumed coverage on shares of Cigna Group in a research report on Tuesday. They set a &#34;buy&#34; rating and a $370.00 price target on the stock. Guggenheim reaffirmed a &#34;buy&#34; rating and set a $350.00 price target (down previously from $388.00) on shares of Cigna Group in a research report on Monday, August 4th. Wells Fargo &amp; Company increased their price target on shares of Cigna Group from $340.00 to $354.00 and gave the stock an &#34;equal weight&#34; rating in a research report on Tuesday, October 7th. Finally, Truist Financial set a $375.00 price target on shares of Cigna Group in a research report on Tuesday, September 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the company presently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $369.89.</p>
<div class="lb-trans"><p>其他股票分析师最近也对该股票发布了报告。Cantor Fitzgerald 在 8 月 26 日的研究报告中重申了 “增持” 评级，并对信诺保险集团的股票设定了 365.00 美元的目标价。高盛集团在周二的研究报告中开始覆盖信诺保险集团的股票，给予 “买入” 评级，并设定 370.00 美元的目标价。Guggenheim 在 8 月 4 日的研究报告中重申了 “买入” 评级，并将信诺保险集团的目标价从 388.00 美元下调至 350.00 美元。富国银行在 10 月 7 日的研究报告中将信诺保险集团的目标价从 340.00 美元上调至 354.00 美元，并给予该股票 “持平” 的评级。最后，Truist Financial 在 9 月 2 日的研究报告中设定了 375.00 美元的目标价。两位股票研究分析师给予该股票 “强烈买入” 评级，十六位分析师给予 “买入” 评级，三位分析师给予 “持有” 评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “适度买入”，共识目标价为 369.89 美元。</p>
</div><p><strong>Read Our Latest Analysis on Cigna Group</strong></p>
<div class="lb-trans"><p><strong>阅读我们对信诺保险集团的最新分析</strong></p>
</div><h2>Cigna Group Price Performance</h2>
<div class="lb-trans"><h2>信诺保险集团价格表现</h2>
</div><ul>
<li>Humana Gains Despite Medicare Advantage Losses—What’s the Catch?</li>
</ul>
<div class="lb-trans"><ul>
<li>尽管医疗保险优势损失，Humana 仍然获利——其中有什么猫腻？</li>
</ul>
</div><p>CI stock opened at $295.86 on Wednesday. The firm has a 50 day moving average of $295.86 and a 200-day moving average of $308.87. Cigna Group has a 12-month low of $256.89 and a 12-month high of $358.88. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The company has a market cap of $78.97 billion, a price-to-earnings ratio of 16.14, a PEG ratio of 0.87 and a beta of 0.45.</p>
<div class="lb-trans"><p>信诺保险集团的 CI 股票在周三开盘价为 295.86 美元。该公司的 50 日移动平均线为 295.86 美元，200 日移动平均线为 308.87 美元。信诺保险集团的 12 个月低点为 256.89 美元，12 个月高点为 358.88 美元。该公司的流动比率为 0.71，速动比率为 0.71，债务与股本比率为 0.65。该公司的市值为 789.7 亿美元，市盈率为 16.14，PEG 比率为 0.87，贝塔值为 0.45。</p>
</div><p>Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm had revenue of $67.13 billion during the quarter, compared to the consensus estimate of $62.61 billion. During the same period in the previous year, the firm posted $6.72 EPS. The company's quarterly revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities analysts expect that Cigna Group will post 29.77 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>信诺保险集团（NYSE:CI - 获取免费报告）最后一次发布季度收益数据是在 7 月 31 日，健康服务提供商报告每股收益（EPS）为 7.20 美元，超出市场共识预期的 7.15 美元，超出 0.05 美元。信诺保险集团的股本回报率为 18.80%，净利润率为 1.92%。该公司在本季度的收入为 671.3 亿美元，而市场共识预期为 626.1 亿美元。在去年同期，该公司每股收益为 6.72 美元。与去年同期相比，该公司的季度收入增长了 11.0%。信诺保险集团已将其 2025 财年的指导目标设定为 29.600-每股收益。整体来看，股票分析师预计信诺保险集团在当前财年将发布 29.77 美元的每股收益。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部买卖情况</h2>
</div><ul>
<li>MarketBeat Week in Review – 01/06 - 01/10</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 01/06 - 01/10</li>
</ul>
</div><p>In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the sale, the insider owned 25,648 shares of the company's stock, valued at $7,694,400. This trade represents a 52.66% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the sale, the insider directly owned 51,182 shares of the company's stock, valued at approximately $15,354,600. The trade was a 9.49% decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.70% of the company's stock.</p>
<div class="lb-trans"><p>在信诺保险集团的其他新闻中，内部人士 Nicole S. Jones 在 8 月 15 日的交易中出售了 28,526 股信诺保险集团的股票。该股票以 300.00 美元的平均价格出售，总交易额为 8,557,800.00 美元。交易完成后，该内部人士持有该公司 25,648 股股票，价值 7,694,400 美元。这笔交易代表其持股比例减少了 52.66%。该出售在向 SEC 的备案中披露，相关信息可在此链接中找到。此外，内部人士 Brian C. Evanko 在 10 月 3 日的交易中出售了 5,368 股信诺保险集团的股票。该股票以 300.00 美元的平均价格出售，总交易额为 1,610,400.00 美元。交易完成后，该内部人士直接持有该公司 51,182 股股票，价值约 15,354,600 美元。这笔交易代表其持股比例减少了 9.49%。该出售的披露信息可以在这里找到。公司内部人士持有该公司 0.70% 的股票。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>Large investors have recently made changes to their positions in the stock. Price T Rowe Associates Inc. MD increased its stake in Cigna Group by 10.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider's stock valued at $3,966,690,000 after acquiring an additional 1,094,327 shares during the period. Massachusetts Financial Services Co. MA grew its stake in Cigna Group by 1.1% during the second quarter. Massachusetts Financial Services Co. MA now owns 11,778,472 shares of the health services provider's stock worth $3,893,727,000 after buying an additional 123,479 shares during the last quarter. Dodge &amp; Cox grew its stake in Cigna Group by 0.7% during the second quarter. Dodge &amp; Cox now owns 8,950,610 shares of the health services provider's stock worth $2,958,893,000 after buying an additional 60,877 shares during the last quarter. GQG Partners LLC grew its stake in Cigna Group by 21.5% during the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider's stock worth $1,607,716,000 after buying an additional 865,092 shares during the last quarter. Finally, Valeo Financial Advisors LLC grew its stake in Cigna Group by 86,071.1% during the second quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider's stock worth $1,148,859,000 after buying an additional 3,471,249 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company's stock.</p>
<div class="lb-trans"><p>大型投资者最近对该股票的持仓进行了调整。Price T Rowe Associates Inc. MD 在第一季度将其在信诺保险集团的持股增加了 10.0%。Price T Rowe Associates Inc. MD 目前持有信诺保险集团的 12,056,806 股股票，价值为 39,666,900,000 美元，在此期间又增持了 1,094,327 股。马萨诸塞金融服务公司在第二季度将其在信诺保险集团的持股增加了 1.1%。马萨诸塞金融服务公司目前持有信诺保险集团的 11,778,472 股股票，价值为 38,937,270,000 美元，在上个季度又增持了 123,479 股。Dodge &amp; Cox 在第二季度将其在信诺保险集团的持股增加了 0.7%。Dodge &amp; Cox 目前持有信诺保险集团的 8,950,610 股股票，价值为 29,588,930,000 美元，在上个季度又增持了 60,877 股。GQG Partners LLC 在第一季度将其在信诺保险集团的持股增加了 21.5%。GQG Partners LLC 目前持有信诺保险集团的 4,886,674 股股票，价值为 16,077,160,000 美元，在上个季度又增持了 865,092 股。最后，Valeo Financial Advisors LLC 在第二季度将其在信诺保险集团的持股增加了 86,071.1%。Valeo Financial Advisors LLC 目前持有信诺保险集团的 3,475,282 股股票，价值为 1,148,859,000 美元，在上个季度又增持了 3,471,249 股。机构投资者和对冲基金持有该公司 86.99% 的股票。</p>
</div><h2>About Cigna Group</h2>
<div class="lb-trans"><h2>关于信诺保险集团</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.</p>
<div class="lb-trans"><p>信诺集团及其子公司在美国提供保险及相关产品和服务。其 Evernorth 健康服务部门提供一系列协调和定点解决方案的健康服务，包括药房福利、家庭送药、专科药房、分销以及向健康计划、雇主、政府组织和医疗服务提供者提供的护理交付和管理解决方案。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Cigna Group</li>
<li>Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time</li>
<li>Domino’s Delivers a Q3 Beat—and a Recipe for a Rebound</li>
<li>Growth Investing: Should You Adopt This Investing Strategy in 2022?</li>
<li>3 Small Caps Hitting 52-Week Highs: Take Profits or Let Ride?</li>
<li>What is a Microcap Stock? Everything You Need to Know</li>
<li>Fluence Energy Could Be a Multi-Bagger Play in Energy Technology</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票：信诺集团</li>
<li>异常交易量的股票：如何实时找到异常交易量股票</li>
<li>达美乐披露第三季度业绩超预期——并提供反弹的食谱</li>
<li>成长投资：你应该在 2022 年采用这种投资策略吗？</li>
<li>3 只小盘股创 52 周新高：获利了结还是继续持有？</li>
<li>什么是微型股？你需要知道的一切</li>
<li>Fluence Energy 可能是能源技术领域的多倍收益投资</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNJ" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=CI"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Cigna Group Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 $1,000 在信诺集团吗？</h2>
</div><p>Before you consider Cigna Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑信诺集团之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而信诺集团并不在名单上。</p>
</div><p>While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然信诺集团目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Wolfe Research 将信诺保险（NYSE:CI）的目标价下调至 325.00 美元